Delamanid

Tuberculosis: Policies should ‘help facilitate access to life saving treatment not create barriers.’

by

Stobdan Kalon is a medical doctor working with Medecins Sans Frontieres/Doctors Without Borders (MSF). His experience spans from managing infectious diseases, interventions in Drug Resistant-Tuberculosis (DR-TB), hepatitis and HIV. As a doctor, I am elated that the World Health Organization (WHO) has updated their DR-TB treatment guidelines, which approves concomitant use of Bedaquiline and Delamanid … Read more

MSF and TB activists disrupt opening of TB conference to protest drug corporations keeping life-saving medicines from people

by

Newer medicines for DR-TB are desperately needed, but barriers to access, including high prices, keep them out of reach for most people around the world. Hyderabad, 30 October – Doctors Without Borders/Médecins Sans Frontières (MSF) joined tuberculosis (TB) activists to disrupt the opening ceremony of the 50th Union World Conference on Lung Health in Hyderabad today, … Read more